ENTITY
BioDlink International

BioDlink International (1875 HK)

74
Analysis
Health Care • China
Develops, manufactures and markets anti-tumor drugs
more
Exchange Announcement • 29 Sep 2026 17:18

Interim Report 2026

Exchange Announcement • 21 Aug 2026 19:46

Interim Results Announcement For The Six Months Ended 30 June 2026

Exchange Announcement • 11 Aug 2026 18:16

Change Of Company Logo

Exchange Announcement • 10 Jul 2026 17:08

Date Of Board Meeting

Exchange Announcement • 26 Jun 2026 19:31

Poll Results Of The Annual General Meeting Held On 26 June 2026

x